The Institute of Neurology and Neurosurgery (INN) at Saint Barnabas prides itself in its involvement in the demanding world of neurological research over the last 20+ years. The INN conducts research associated with a variety of neurological disorders with a particular focus in adult and childhood epilepsies, as well as studies in autism spectrum disorder. Investigational drug and product studies are constantly being conducted to bring new and improved anti-epileptic drugs to the market. The following investigational drug trials  are currently being conducted at INN. The study links are available at

Open to Enrollment:

  • BHV7000-302: To determine safety and Efficacy of BHV7000 in Adults with Refractory Focal Onset Epilepsy.
  • BHV7000-301: A Long term Open-Label study for those completed 12-week double-blind study.
  • BHV7000-304: To Determine Safety, Efficacy and Tolerability of BHV7000 in patients with Idiopathic Generalized Epilepsy with Open-Label Extension study.
  • Protocol:TAK-935-3002 : A Double-Blind study for Lennox-Gastaut syndrome (LGS) Identifier: NCT04938427

  • Protocol: TAK-935-3003: An Open-label study for Lennox-Gastaut syndrome(LGS) Identifier: NCT05163314

  • HEP3: Human Epilepsy study for newly diagnosed, treatment responsive , or treatment resistant Idiopathic generalized Epilepsy in adolescents and Adults  (Institutional study in collaboration with NYU)

If you are interested in participating or learning more about our research please contact Munazza Malik, MD

Phone: 973-322-7425.